South Rampart Pharma Doses First Patient in Phase 1 Multiple Ascending Dose Trial of SPR-001
South Rampart Pharma Doses First Patient in Phase I Multiple Ascending Dose Trial of SPR-001 – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics – – Data expected in 3Q 2023 – NEW ORLEANS, Aug. 22, 2023 /PRNewswire/ … Read more